, Volume 22, Issue 3, pp 193–201

HSP90 is a key for telomerase activation and malignant transition in pheochromocytoma

  • Carsten Boltze
  • Hendrik Lehnert
  • Regine Schneider-Stock
  • Brigitte Peters
  • Cuong Hoang-Vu
  • Albert Roessner


Recent studies on a limited number of pheochromocytomas (PCs) revealed a potential role of telomerase in the malignant transition of these tumors. Telomerase is a ribonucleoprotein complex that includes the telomerase RNA component (hTR), the telomerase-associated protein (TP1), the telomerase catalytic subunit (hTERT), and the heat-shock protein 90 (HSP90). The interactions between these subunits and the activation machinery of telomerase are still unclear. To test whether the expression and regulation of telomerase subunits are reflected in the malignant transition of PCs, we determined their mRNA and/or protein expression in 28 benign and 9 malignant PCs and compared the results with telomerase activity. Reverse transcriptase polymerase chain reaction analysis revealed that TP1 was ubiquitously expressed. hTR was found in all malignant (100%) and in 13/28 (46%) benign PCs. By contrast, hTERT was clearly associated with aggressive biologic behavior. All the malignant (100%) but only 2/28 benign (7%) PCs expressed hTERT. HSP90 was increased in malignant PCs but was also expressed at a lower level in benign tumors. High telomerase activity was measurable in only hTERT-positive tissues. Our data indicate that hTERT, HSP90, and telomerase activity are upregulated in malignant cells of the adrenal medulla. Over-expression of HSP90 is an important factor in the activation of telomerase via hTERT. The common expression of hTERT and telomerase activity thus represents an additional prognostic marker that may identify more aggressive tumors.

Key Words

HSP90 telomerase pheochromocytoma hTERT 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Levy, M. Z., Allsopp, R. C., Futcher, A. B., Greider, C. W., and Harley, C. B. (1992). J. Mol. Biol. 225, 951–960.PubMedCrossRefGoogle Scholar
  2. 2.
    Avilion, A. A., Piatyszek, M. A., Gupta, J., Shay, J. W., Bacchetti, S., and Greider, C. W. (1996). Cancer Res. 56, 645–650.PubMedGoogle Scholar
  3. 3.
    Nakamura, T. M., Morin, G. B., Chapman, K. B., et al. (1997). Science 277, 955–959.PubMedCrossRefGoogle Scholar
  4. 4.
    Holt, S. E., Aisner, D. L., Baur, J., et al. (1999). Genes Dev. 13, 817–826.PubMedGoogle Scholar
  5. 5.
    Masutomi, K., Kaneko, S., Hayashi, N., et al. (2000). J. Biol. Chem. 275, 22568–22573.PubMedCrossRefGoogle Scholar
  6. 6.
    Lundblad, V. (1998). Proc. Natl. Acad. Sci. USA 95, 8415–8416.PubMedCrossRefGoogle Scholar
  7. 7.
    Harrington, L., McPhail, T., Mar, V., et al. (1997). Science 275, 973–977.PubMedCrossRefGoogle Scholar
  8. 8.
    Zhu, X., Kumar, R., Mandal, M., et al. (1996). Proc. Natl. Acad. Sci. USA 93, 6091–6095.PubMedCrossRefGoogle Scholar
  9. 9.
    Linnoila, R. I., Keiser, H. R., Steinberg, S. M., and Lack, E. E. (1990). Hum. Pathol. 21, 1168–1180.PubMedCrossRefGoogle Scholar
  10. 10.
    Goldstein, R. E., O’Neill, J. A. Jr., Holcomb, G. W. III, et al. (1999). Ann. Surg. 229, 755–764.PubMedCrossRefGoogle Scholar
  11. 11.
    John, H., Ziegler, W. H., Hauri, D., and Jaeger, P. (1999). Urology 53, 679–683.PubMedCrossRefGoogle Scholar
  12. 12.
    Clarke, M. R., Weyant, R. J., Watson, C. G., and Carty, S. E. (1998). Hum. Pathol. 28, 522–526.CrossRefGoogle Scholar
  13. 13.
    Mundschenk, J. and Lehnert, H. (1998). Exp. Clin. Endocrinol. Diabetes 106, 373–376.PubMedCrossRefGoogle Scholar
  14. 14.
    Okayasu, I., Mitomi, H., Yamashita, K., et al. (1998). J. Cancer Res. 124, 444–449.Google Scholar
  15. 15.
    Katayama, S., Shiota, G., Oshimura, M., and Kawasaki, H. (1999). J. Cancer Res. 125, 405–410.CrossRefGoogle Scholar
  16. 16.
    Poremba, C., Böcker, W., Willenbring, H., et al. (1998). Int. J. Oncol. 12, 641–648.PubMedGoogle Scholar
  17. 17.
    Hoang-Vu, C., Boltze, C., Gimm, O., et al. (2002). Int. J. Oncol. 21, 265–272.PubMedGoogle Scholar
  18. 18.
    Schneider-Stock, R., Boltze, C., Jäger, V., et al. (2003). J. Pathol. 199, 517–525.PubMedCrossRefGoogle Scholar
  19. 19.
    Harley, C. B. (1991). Mutat. Res. 256, 271–282.PubMedGoogle Scholar
  20. 20.
    Feng, J., Funk, W. D., Wang, S. S., et al. (1995). Science 269, 1236–1241.PubMedCrossRefGoogle Scholar
  21. 21.
    Ramakrishnan, S., Eppenberger, U., Mueller, H., Shinkai, Y., and Narayanan, R. (1998). Cancer Res. 58, 622–625.PubMedGoogle Scholar
  22. 22.
    Nakayama, J., Tahara, H., Tahara, E., et al. (1998). Nat. Genet. 18, 65–68.PubMedCrossRefGoogle Scholar
  23. 23.
    Bamberger, C. M., Else, T., Bamberger, A. M., et al. (1999). Exp. Clin. Endocrinol. Diabetes 107, 272–275.PubMedCrossRefGoogle Scholar
  24. 24.
    Kinoshita, H., Ogawa, O., Mishina, M., et al. (1998). Urol. Res. 26, 29–32.PubMedCrossRefGoogle Scholar
  25. 25.
    Kubota, Y., Nakada, T., Sasagawa, I., Yanai, H., and Itoh, K. (1998). Cancer 82, 176–179.PubMedCrossRefGoogle Scholar
  26. 26.
    Aogi, K., Kitahara, K., Buley, M., et al. (1998). Clin. Cancer Res. 4, 1965–1970.PubMedGoogle Scholar
  27. 27.
    Saji, M., Xydas, S., Westra, W. H., et al. (1999). Clin. Cancer Res. 5, 1483–1489.PubMedGoogle Scholar
  28. 28.
    Chang, J. T. C., Chen, Y. L., Yang, H. A. T., Chen, C. Y., and Cheng, A. J. (2002). Eur. J. Biochem. 269, 3442–3450.PubMedCrossRefGoogle Scholar
  29. 29.
    Hutchinson, K. A., Stancato, L. F., Owens-Grillo, J. K., et al. (1995). J. Biol. Chem. 270, 18841–18847.CrossRefGoogle Scholar
  30. 30.
    Remmele, W., Hildebrand, U., and Hienz, H. (1986). Virchows Arch. 409, 127–147.CrossRefGoogle Scholar
  31. 31.
    Kim, N. W. and Wu, F. (1997). Nucleic Acids Res. 25, 2595–2597.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc 2003

Authors and Affiliations

  • Carsten Boltze
    • 4
  • Hendrik Lehnert
    • 1
  • Regine Schneider-Stock
    • 4
  • Brigitte Peters
    • 2
  • Cuong Hoang-Vu
    • 3
  • Albert Roessner
    • 4
  1. 1.Department of Endocrinology and MetabolismOtto-von-Guericke-University MagdeburgMagdeburgGermany
  2. 2.Department of BiometricsOtto-von-Guericke-University MagdeburgMagdeburgGermany
  3. 3.Clinic of General SurgeryMartin-Luther-University Hale-WittenbergHalleGermany
  4. 4.Department of PathologyOtto-von-Guericke-UniversityMagdeburgGermany

Personalised recommendations